OptimizeRx.png
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
April 16, 2024 07:00 ET | OptimizeRx Corporation
Q4 revenue of $28.4 million, increasing 44% year-over-yearQ4 gross profit increased 43% year-over-year to $17.8 million with gross margins coming in at 63% for both periodsAcquired Healthy Offers,...
OptimizeRx.png
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
April 11, 2024 07:30 ET | OptimizeRx Corporation
WALTHAM, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx.png
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
March 25, 2024 07:30 ET | OptimizeRx Corporation
WALTHAM, Mass., March 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx.png
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
March 11, 2024 16:30 ET | OptimizeRx Corporation
WALTHAM, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx.png
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
March 04, 2024 15:51 ET | OptimizeRx Corporation
WALTHAM, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx.png
OptimizeRx to Participate in Upcoming Investor Conferences
February 21, 2024 07:30 ET | OptimizeRx Corporation
WALTHAM, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx.png
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
January 25, 2024 07:30 ET | OptimizeRx Corporation
WALTHAM, Mass., Jan. 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx.png
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
January 09, 2024 07:30 ET | OptimizeRx Corporation
WALTHAM, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx.png
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
December 18, 2023 07:30 ET | OptimizeRx Corporation
WALTHAM, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx.png
OptimizeRx Reports Third Quarter 2023 Financial Results
November 06, 2023 07:00 ET | OptimizeRx Corporation
- Increases guidance for 2023 and introduces guidance for 2024- Total revenue of $16.3 million- GAAP net loss per share of $(0.17)- Non-GAAP net income per share of $0.09- Total DAAP (fka RWD) deals...